Capecitabine (Shilpa Medicare Limited)
Welcome to the PulseAid listing for the Capecitabine drug offered from Shilpa Medicare Limited. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Shilpa Medicare Limited |
NON-PROPRIETARY NAME: | Capecitabine |
SUBSTANCE NAME: | CAPECITABINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-12-31 |
END MARKETING DATE: | 0000-00-00 |
Capecitabine HUMAN PRESCRIPTION DRUG Details:
Item Description | Capecitabine from Shilpa Medicare Limited |
LABELER NAME: | Shilpa Medicare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2016-12-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63759-3000_35f3619e-3301-4410-8de1-33ae333b56d5 |
PRODUCT NDC: | 63759-3000 |
APPLICATION NUMBER: | ANDA207456 |
Other CAPECITABINE Pharmaceutical Manufacturers / Labelers: